Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tuberculosis in circulation system]

N Ashizawa1, K Yano

  • 1Third Department of Internal Medicine, Nagasaki University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 12, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distribution and correlates of insulin in elderly men. The Honolulu Heart Program.

Arteriosclerosis, thrombosis, and vascular biology·1995
Same author

Low serum cholesterol and mortality. Which is the cause and which is the effect?

Circulation·1995
Same author

[Antitumor effect of MMC mixed in Beriplast P].

Gan to kagaku ryoho. Cancer & chemotherapy·1995
Same author

[Immunopotentiation by OK-432 ointment to apply to the mouse abdominal skin].

Gan to kagaku ryoho. Cancer & chemotherapy·1995
Same author

Development of a rat model for orthotopic liver transplantation for hepatocellular carcinoma.

Surgery·1995
Same author

[A case of duodenal Brunner's gland hyperplasia associated with in situ carcinoma].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·1995
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Tuberculous pericarditis, caused by Mycobacterium tuberculosis, presents as fluid accumulation around the heart. Diagnosis aids include PCR and elevated ADA levels, with treatment involving a three-drug regimen.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Microbiology

Context:

  • Tuberculous pericarditis arises from Mycobacterium tuberculosis spread.
  • Pathological hallmarks include fibrin deposits, granulomas, and bacilli presence.
  • Pericardial effusions are typically serous, hemorrhagic, and protein-rich.

Purpose:

  • To outline the pathogenesis, diagnosis, and treatment of tuberculous pericarditis.
  • To highlight diagnostic tools such as PCR and Adenosine Deaminase (ADA) levels.
  • To discuss treatment strategies and the controversial role of prednisolone.

Summary:

  • Tuberculous pericarditis involves Mycobacterium tuberculosis infection of the pericardium.
  • Diagnosis is supported by PCR detection of M. Tuberculosis DNA and elevated ADA levels (> 45 U/l).

Related Experiment Videos

  • Treatment typically involves a three-drug regimen (e.g., INH, RFP, PZA, SM, EB), with prednisolone use debated.

    • Impact:

    • Informs clinical diagnosis and management of tuberculous pericarditis.
    • Emphasizes the utility of molecular diagnostics and biochemical markers.
    • Contributes to understanding the clinical course and therapeutic options for this serious infection.